Overview: The molecular medicine of mental retardation and developmental disabilities
โ Scribed by McCabe, Edward R. B.
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 129 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1080-4013
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
reatment decisions on behalf of developmentally disabled persons who are not capable of making their own autonomous choices have been, and likely will continue to be, contested terrain. The past two decades have seen the court battles over forgoing life-sustaining medical treatment for severely neur
Mental retardation (MR) is one of the few clinically important disorders for which the etiopathogenesis is still poorly understood. It is a condition of great concern for public health and society. MR is currently defined as a significant impairment of cognitive and adaptive functions, with onset be
## Abstract The human and mouse genome projects elucidated the sequence and position map of innumerous genes expressed in the central nervous system (CNS), advancing our ability to manipulate these sequences and create models to investigate regulation of gene expression and function. In this articl
To various degrees, psychopharmacologic medications are associated with side effects. Despite improvements in newer psychopharmacologic medication, monitoring for side effects remains important for individuals with mental retardation and developmental disabilities for a number of reasons, of which p